Vfend 50 mg – DIN 02256460
Vfend is Voriconazole 50 mg (tablet), sold in Canada. It is used for yeast infections, aspergillosis and fusariosis. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Voriconazole 50 mg
- Brand
- Vfend
- Strength
- 50 mg
- Used for
- Yeast infections, aspergillosis and fusariosis
- Form
- Tablet
- Manufacturer
- Pfizer Canada ULC
- Drug class
- Antifungal
- Sold in
- Canada
- DIN
- 02256460
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Voriconazole used for?
Voriconazole is used for yeast infections, aspergillosis and fusariosis.
- Medicine type
- Antifungal
Official uses from the US prescribing label
Invasive Aspergillosis
Voriconazole tablets are indicated in adults and pediatric patients (2 years of age and older) for the treatment of invasive aspergillosis (IA). In clinical trials, the majority of isolates recovered were Aspergillus fumigatus. There was a small number of cases of culture-proven disease due to species of Aspergillus other than A. fumigatus.
Candidemia in Non-neutropenic Patients and Other Deep Tissue Candida Infections
Voriconazole tablets are indicated in adults and pediatric patients (2 years of age and older) for the treatment of candidemia in non-neutropenic patients and the following Candida infections: disseminated infections in skin and infections in abdomen, kidney, bladder wall, and wounds.
Esophageal Candidiasis
Voriconazole tablets are indicated in adults and pediatric patients (2 years of age and older) for the treatment of esophageal candidiasis (EC) in adults and pediatric patients 2 years of age and older.
Scedosporiosis and Fusariosis
Voriconazole tablets are indicated for the treatment of serious fungal infections caused by Scedosporium apiospermum (asexual form of Pseudallescheria boydii) and Fusarium spp.including Fusarium solani, in adults and pediatric patients (2 years of age and older) intolerant of, or refractory to, other therapy.
Usage
Specimens for fungal culture and other relevant laboratory studies (including histopathology) should be obtained prior to therapy to isolate and identify causative organism(s). Therapy may be instituted before the results of the cultures and other laboratory studies are known. However, once these results become available, antifungal therapy should be adjusted accordingly.
From the FDA-approved label on DailyMed (published Aug 31, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02256460.
- It names Vfend, Voriconazole 50 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Vfend by Pfizer Canada ULC.
In Canada: prescription only.
Ingredients
Active: Voriconazole
Other Voriconazole pills
-
573 G
Voriconazole 200 mg
White, oval, 16 mm
Used for yeast infections and aspergillosis
-
73 G
Voriconazole 50 mg
White, round, 7 mm
Used for yeast infections and aspergillosis
- V2 Voriconazole 200 mg White, capsule, 7 mm Used for yeast infections and aspergillosis
- SZ 133 Voriconazole 200 mg White, capsule, 6 mm Used for yeast infections and aspergillosis
- CC 53 Voriconazole 200 mg White, oval, 16 mm Used for yeast infections and aspergillosis
- M164 Voriconazole 200 mg White, oval, 16 mm Used for yeast infections and aspergillosis
- Pfizer VOR200 Voriconazole 200 mg White, capsule, 15 mm Used for yeast infections and aspergillosis
- 736 Voriconazole 200 mg White, oval, 16 mm Used for yeast infections and aspergillosis